Monday, 4 January 2016

Biopreservation Market Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies, and Forecasts, 2015 To 2022



The global biopreservation market is expected to reach USD 9.34 billion by 2022, according to a new report by Grand View Research Inc. Increasing demand for novel bio-preservation techniques and constantly rising healthcare expenditure is expected to boost the market growth over the forecast period. Adoption of in-house sample storage system by hospitals, biotechnology and pharmaceutical companies is one of the critical success factors for the growth of the industry over next seven years.
Additionally, increasing R&D investments by various research organizations and companies to enhance their capabilities to render efficient and effective products & services is a high impact rendering driver expected to boost bio-preservation market growth. Furthermore, as a consequence of technological advancements such as introduction of virtual bio-banks, bio-preservation is witnessing increased application in end-use hence boosting the growth of bio-preservation market.

North America biopreservation market, by product, 2012-2022 (USD Million)
North America biopreservation market 

Further key findings from the report suggest:
  • Equipment dominated the overall product segment in 2014, with the revenue share of over 80%. Key factors attributing to its large share include rising demand of bio-banks coupled with high cost for preservation of bio-specimens.  
  • Media, which encompasses pre-formulated and home-brew media is expected to witness high growth over the forecast period as a consequence of their wide usage in regenerative medicines.
  • Bio-banking dominated was the key application segment of bio-preservation in 2014, with lucrative market share owing to increasing number of organ and tissue transplantations, high patient awareness levels and rise in healthcare expenditure.
  • Regenerative medicine is estimated to grow at a rate of over 18% as a result of huge investments made by government, and non government organizations in the field of regenerative cell therapy research.
  • Tumor cells held the largest share in volume terms in 2014, owing to their wide applications in research & development, diagnosis, and treatment of highly prevalent cancer.
  • North America dominated the overall industry in 2014 with over 45% revenue share majorly due to favorable government regulations in North America which are supporting the ethical usage and sharing of biological samples.
  • Asia Pacific is expected to grow at substantial rate during the forecast period as a consequence of high unmet needs amongst the population in the region coupled with constantly improving healthcare infrastructure as a result of government initiatives such as Make In India.
  • Key players of the bio-preservation market include BioCision, Biomatrica, BioLife Solutions Inc., Chart MVE Biomedical, LabVantage Solutions Inc., Atlanta Biologicals, Panasonic Biomedical, Thermo Fisher Scientific Inc. and Qiagen. These companies are involved in various developmental strategies such as mergers and acquisitions to sustain their market share.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global biopreservation market on the basis of products, application, cell providers and region:
Biopreservation Product Outlook (Revenue, USD Billion, 2012 – 2022)
  • Equipment
    • Freezers
    • Refrigerators
    • Consumables
      • Vials
      • Straws
      • Microtiter Plates
      • Bags
    • Liquid Nitrogen
  • Media
    • Pre-formulated
    • Home-brew
  • Laboratory Information Management System (LIMS)
Biopreservation Application Outlook (Revenue, USD Billion, 2012 – 2022)
  • Regenerative Medicine
    • Cell therapy
    • Gene therapy
    • Others
  • Bio-banking
    • Human eggs
    • Human sperms
    • Veterinary IVF
  • Drug Discovery
Biopreservation Cell Providers Outlook (Volume, Number of Units, 2012 – 2022)
  • CD34+
  • CD19+
  • MSC
  • iPSC
  • hESC
  • Tumor Cells
  • Others
Biopreservation Market Regional Outlook (Revenue, USD Billion, 2012 – 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          


Sunday, 3 January 2016

Cell Banking Outsourcing Market Hits $9.87 Billion By 2022: Grand View Research, Inc.



The global cell banking outsourcing market is expected to reach USD 9.87 billion by 2022, according to a new report by Grand View Research, Inc. Factors attributing towards this anticipated market size include growing demand for gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites.
Additionally, rise in prevalence of oncology associated diseases and other infectious chronic disorders are expected to promote cytological R&D in which cell banking plays a pivotal role thereby driving growth. R&D for commercialization of novel characterization and cryopreservation methods is also expected to considerably enhance lucrative growth opportunities over the forecast period.

U.S. cell banking outsourcing market, by cell type, 2012-2022 (USD Million)
U.S. cell banking outsourcing market 

Further key findings from the report suggest:
  • Master cell banks accounted for over 60% of revenue generated in 2014 owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for stem cell therapy and gene therapy thereby resulting to segment growth.
  • Stem cells accounted for the largest share with respect to revenue in cell banking market by cell type. Factors attributive towards large share of this segment include availability of stem cells from different organ origins and there consequent use in different metabolic disorders.
  • North America accounted for the largest share of this market for 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for vaccines and biopharmaceuticals is also anticipated to fuel the growth of this region.
  • Asia Pacific is expected to witness significant growth in demand over the forecast period owing to increase in number of supportive government initiatives pertaining to investments in biotechnology sector. Additionally, ongoing R&D activities for cancer treatment and fertility preservation facilitate the demand for cell banking services.
  • Key participants in the cell banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., and CordLife.
  • Market participants are involved in R&D for characterization of cell banks which include introduction of efficient gene sequencing tests, karyology, and safety tests.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented cell banking outsourcing market on the basis of bank type, cell type, phase of development of cell bank, and region:
Cell Banking Outsourcing Outlook, by Bank Type (Revenue, USD Million, 2012 - 2022 )
  • Master Cell Banking
  • Working Cell Banking
  • Viral Cell Banking
Cell Banking Outsourcing Outlook, by Cell Type (Revenue, USD Million, 2012 - 2022 )
  • Stem Cell Banking
    • Cord Stem Cell Banking
    • Embryonic Stem Cell Banking
    • Adult Stem Cell Banking
    • Dental Stem Cell Banking
    • IPS Stem Cell Banking
  • Non-stem Cell Banking
Cell Banking Outsourcing Phase Outlook (Revenue, USD Million, 2012 - 2022 )
  • Cell Bank Storage
    • Master Cell Bank Storage
    • Working Cell Bank Storage
    • Cell Storage Stability Testing
  • Bank Characterization and Testing
    • Safety Testing
      • Viral Cell Bank Safety Testing
      • Microbial Cell Bank Safety Testing
      • Gene Expression Testing
      • Karyology Testing
      • Gene Sequencing Testing
  • Cell Bank Preparation
    • Master Cell Bank Preparation
    • Working Cell Bank Preparation
Cell Banking Outsourcing Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
    • Korea
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          


Epigenetics Market Analysis, Growth, Trends To 2022: Grand View Research, Inc.



The global epigenetics market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.
Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.
Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.
Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

U.S. epigenetics market, by product, 2012-2020, (USD Million)
U.S. epigenetics market
 
Further key findings from the report suggest:
  • Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
  • DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.
  • Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.
  • Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.
  • North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.
  • The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs
  • Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.
  • Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period. 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:
Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)
  • Reagents
  • Kits
  • Instruments
  • Enzymes
  • Services
Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large noncoding RNA
  • MicroRNA Modification
  • Chromatin structures
Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)
  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
Epigenetics Market  Regional Outlook(Revenue, USD Million, 2015 – 2022)
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research